The recent finding that DHX34 is subject to alternative splicing in sporadic AML leading to the inclusion of a poison exon that results in AS-NMD highlighted the fact that DHX34 can be inactivated in familial AML not only via mutation but also through alternative splicing regulation (Rivera et al. 2021). The gene discussed is DHX34; the disease is acute myeloid leukemia.